Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Missouri for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Missouri only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Missouri (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Mark Box (NPI 1477604817)

Field	Value
Entity Type	Individual
Organization	Mark Box
Address	1010 Carondelet Dr
City	Kansas City
State	MO
ZIP	64114
Taxonomy	Rheumatology Physician
NPI Enumerated	January 14, 2007

Payer Source	Total Paid
Medicare	$1.3M
Medicaid	$0

Key Findings

This provider’s outpatient billing is effectively single‑payer: Total Medicare revenue is $1.3M while there is no Medicaid billing on file. The NPI was enumerated 2007-01-14 (~19 years ago), indicating an established practice footprint in Kansas City, MO focused on Medicare beneficiaries.

Revenue is highly concentrated in three infused biologic products: J1602 (33.7K claims, $337K revenue; 26.3% of this provider's total Medicare revenue), J1745 (10.2K claims, $263.9K revenue; 20.6% of this provider's total Medicare revenue), and J3262 (63.8K claims, $255.1K revenue; 19.9% of this provider's total Medicare revenue). Precomputed figures show these top three codes account for 66.8% of the provider’s Medicare revenue, signaling material dependence on high-cost injectable biologics.

The mix of high-volume J1602, J1745, and J3262 claims — all monoclonal antibody or biologic infusions used in rheumatologic care — points to an infusion-centered rheumatology operation that bills and administers clinic-based biologic therapies. Supporting line items such as J7050 (676 claims, $676 revenue) and multiple infusion administration codes (96374, 96372, 96375) reinforce that the practice provides on‑site infusion services rather than predominantly prescribing self‑administered therapies.

Competitive standing against national peers is mixed: J1745 ranks #88 of 1352 (94th percentile) and J1602 ranks #119 of 1041 (89th percentile), both described as typical but at upper national percentiles, indicating a stronger‑than‑average presence for those specific biologics; by contrast J3262 ranks #157 of 618 (75th percentile) and is characterized as typical, reflecting a solid but less exceptional position for tocilizumab. Other biologic/osteoporosis injections such as J0897 (9.9K claims, $178.2K revenue; 13.9% of Medicare revenue) also sit in high percentiles (88th) but are described as typical, suggesting the provider competes actively in high-cost injectable therapy lines without being a nationwide outlier for most drugs.

Office visit volume is unusually high relative to peers: 99214 shows 1.1K claims and $95.8K revenue (7.5% of Medicare revenue) and is flagged as an extreme outlier (ranks #8159 of 479517, 98th percentile; far above typical national volume). This indicates disproportionate E/M throughput per Medicare beneficiary compared with most clinicians and may reflect frequent follow‑ups associated with infusion management or complex chronic care.

The practice also bills notable infusion/chemotherapy administration codes at well‑above‑typical rates: 96413 appears with 695 claims and $66.7K revenue (5.2% of Medicare revenue) and is characterized as notably above typical national volume (96th percentile), while 96415 (306 claims, $6.4K revenue) is at the 95th percentile. These patterns underline operational capacity for sustained IV infusions and multi‑hour infusion sessions beyond brief injection visits.

Non‑infusion services and minor revenue streams are present but small: 99213 (691 claims, $45.6K revenue; 3.6% of Medicare revenue) and procedural items such as 20610 (96 claims, $5.2K revenue) and 77080 (57 claims, $2.1K revenue) appear at typical volumes, while influenza vaccine codes (90662 and G0008) contribute modestly. Together these items show a broader ambulatory rheumatology service mix but do not materially dilute reliance on infused biologics.

Taken together, the data portray an established, Medicare‑focused rheumatology practice that derives the majority of revenue from clinic‑administered biologic infusions (66.8% concentrated in the top three codes). The absence of Medicaid billing on file limits exposure to that payer and concentrates payer risk on Medicare reimbursement dynamics and utilization of high‑cost injectable therapies.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

24 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J1602	Injection, golimumab, 1 mg, for intravenous use	33,700	$10	$337K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	10,150	$30	$263.9K
J3262	Injection, tocilizumab, 1 mg	63,770	$1	$255.1K
J0897	Injection, denosumab, 1 mg	9,900	$20	$178.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,140	$80	$95.8K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	700	$100	$66.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	690	$70	$45.6K
96415	In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the…	310	$20	$6.4K
90662	This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection…	90	$70	$6.4K
20610	In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may inject a…	100	$50	$5.2K

Showing 1–10 of 24

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 24 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Missouri Distribution

Mark Box — 4 of 24 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Missouri

Full comparison — all codes billed, vs. state median

24 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J1602	7	20	13,150	$10	$266.8K
J3262	4	10	40,980	$1	$236.8K
J1745	3	40	3,060	$30	$118.1K
J0897	23	210	2,400	$20	$82.4K
96413	4	160	140	$100	$19.1K
99214	82	8,960	100	$80	$13.9K
99213	186	8,730	70	$50	$7K
99204	2,511	4,360	30	$100	$4.8K
90662	344	1,510	40	$70	$4.6K
20610	285	830	60	$40	$4.6K

Showing 1–10 of 24

Related Providers

Other providers that share a Tax Identification Number (TIN) with Mark Box, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
David Dyer	KS	Ophthalmology Physician	$7.5M	$0
Bassam Mattar	KS	Hematology & Oncology Physician	$7.2M	$0
Pavan Reddy	KS	Hematology & Oncology Physician	$6.7M	$0
Jeremy Deutsch	KS	Hematology & Oncology Physician	$5.7M	$0
Thomas Finley	OK	Ophthalmology Physician	$4.8M	$0
Daniel Feiler	KS	Ophthalmology Physician	$4.8M	$0
Travis Koeneke	KS	Hematology & Oncology Physician	$4.4M	$0
Christopher Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0
Stephen Wiles	MO	Ophthalmology Physician	$4.4M	$0
Shaker Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0

Nearby Providers

Other providers in the same ZIP code as Mark Box, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Cornerstones Of Care	MO	Mental Illness Community Based Residential Treatment Facility	$0	$7M
Sherwood Center For The Exceptional Child	MO	Developmentally Disabled Services Day Training Agency	$0	$6.3M
Spiral Health Systems Inc.	MO	In Home Supportive Care Agency	$0	$4.9M
Prime Healthcare Services - Kansas City, LLC	MO	General Acute Care Hospital	$0	$4.4M
John Rupp	MO	Dermatology Physician	$747.1K	$0
John Armilio	MO	Family Medicine Physician	$632.3K	$0
Ramilo Gatapia	MO	Internal Medicine Physician	$213.8K	$401.5K
Thad Stephens	MO	Undersea and Hyperbaric Medicine (Emergency Medicine) Physician	$309K	$0
Patrick Perkins	MO	Pulmonary Disease Physician	$281.1K	$0
William White	MO	Ophthalmology Physician	$262.4K	$0

Mark Box — Billing Profile & Reimbursement Data

Sign up for Mark Box — Billing Profile & Reimbursement Data policy alerts

Mark Box — Billing Profile & Reimbursement Data

Sign up for Mark Box — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References